Mary Ackenhusen
Amministratore Delegato presso Vancouver Coastal Health Research Institute
Provenienza dei contatti di primo grado di Mary Ackenhusen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Vancouver Coastal Health Research Institute
 Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mary Ackenhusen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of British Columbia | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| REPLICEL LIFE SCIENCES INC. | Pharmaceuticals: Major | Founder | |
| University of Aberdeen | College/University | Undergraduate Degree | |
| University Of Dundee | College/University | Doctorate Degree | |
TrichoScience Innovations, Inc.
 TrichoScience Innovations, Inc. Medical/Nursing ServicesHealth Services TrichoScience Innovations, Inc. provides hair cell replication services. The company was founded by Kevin McElwee, Jerry Shapiro, Rolf Hoffmann and Matthew J. Wayrynen and is headquartered in Vancouver, Canada. | Medical/Nursing Services | Founder | |
| University of Bradford | College/University | Corporate Officer/Principal | |
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Vancouver General Hospital | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Canada | 6 |
| Regno Unito | 4 |
Settori
| Consumer Services | 5 |
| Health Technology | 3 |
| Health Services | 2 |
Posizioni
| Corporate Officer/Principal | 6 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Chairman | 2 |
| Undergraduate Degree | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Kevin McElwee | 7 |
| Neil E. Reiner | 4 |
| Kip Woodward | 1 |
- Borsa valori
- Insiders
- Mary Ackenhusen
- Connessioni Società
